片仔癀：母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊

证券之星08-10 15:34

证券之星消息，片仔癀(600436)08月10日在投资者关系平台上答复投资者关心的问题。

投资者提问：请问母公司销售给子公司的产品，再由子公司对外销售，对外销售的营收归属于医药制造还是医药流通？

片仔癀回复：尊敬的投资者您好，母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊。感谢您的关注！

本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。

相关 ETF

责任编辑：陈思雨

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2658986892?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-10 15:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2658986892","market":"sh","top_or_hot":-1,"title":"片仔癀：母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/600436\">片仔癀</a>(600436)08月10日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：请问母公司销售给子公司的产品，再由子公司对外销售，对外销售的营收归属于医药制造还是医药流通？</p><p>片仔癀回复：尊敬的投资者您好，母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊。感谢您的关注！</p><p>本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。</p><h2>相关 ETF</h2><p><img src=\"https://static.stockstar.com/etf/15978120260809.png\"/><img src=\"https://static.stockstar.com/etf/51058020260809.png\"/><img src=\"https://static.stockstar.com/etf/58808020260809.png\"/><img src=\"https://static.stockstar.com/etf/51201020260809.png\"/></p><p>责任编辑：陈思雨</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>片仔癀：母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n片仔癀：母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-10 15:34 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026081000014074.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，片仔癀(600436)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问母公司销售给子公司的产品，再由子公司对外销售，对外销售的营收归属于医药制造还是医药流通？片仔癀回复：尊敬的投资者您好，母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026081000014074.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600436","symbol_name":"片仔癀","start_time":0,"source_url":"https://stock.stockstar.com/RB2026081000014074.shtml","article_id":"2658986892","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2658986892","pubTimestamp":1786347261,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，片仔癀(600436)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问母公司销售给子公司的产品，再由子公司对外销售，对外销售的营收归属于医药制造还是医药流通？片仔癀回复：尊敬的投资者您好，母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：陈思雨","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","600436":"片仔癀","09939":"开拓药业-B"},"translate_title":"Pien Tze Huang: The products sold by the parent company to the pharmaceutical distribution subsidiary, and the operating income realized by the external sales of the pharmaceutical distribution subsidiary is shared by the pharmaceutical manufacturing industry and the pharmaceutical distribution industry","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1.5,"600436":1.5,"09939":1.5},"content_text":"证券之星消息，片仔癀(600436)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问母公司销售给子公司的产品，再由子公司对外销售，对外销售的营收归属于医药制造还是医药流通？片仔癀回复：尊敬的投资者您好，母公司销售给医药流通子公司的产品，再由医药流通子公司对外销售实现的营业收入由医药制造业和医药流通业共同分摊。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：陈思雨","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2658986892","isCrawlerRequest":true}